This brand name is authorized in Austria, Estonia, Finland, Croatia, Poland, Romania
The drug APEXXNAR contains one active pharmaceutical ingredient (API):
|
1
Pneumococcus, purified polysaccharides antigen
UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE
|
|
|
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| APEXXNAR Suspension for injection | European Medicines Agency (EU) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| J07AL02 | Pneumococcus, purified polysaccharides antigen conjugated | J Antiinfectives for systemic use → J07 Vaccines → J07A Bacterial vaccines → J07AL Pneumococcal vaccines |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EE | Ravimiamet | Identifier(s): 1875135, 1875146, 1875157 |
| Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 182303, 458025 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100467708 |
| Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W68478001, W68478002, W68478003, W68478004, W68478005, W68478006 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
